Foxetin - Foxetin is an antidepressant, propylamine derivative. The mechanism of action is associated with selective blockade of the inverse of neuronal serotonin reuptake in the CNS. Foxetin is a weak antagonist of choline, adrenergic and histamine receptors. Unlike most antidepressants Foxetin apparently does not cause reduction of functional activity of postsynaptic beta-adrenergic receptors. This medication improves mood, reduces anxiety and stress, eliminates dysphoria. Foxetin does not cause sedation. When you receive a medium therapeutic doses of this drug it does not affect the function of cardiovascular and other systems.
Foxetin, an antidepressant agent belonging to the selective serotonin reuptake inhibitors (SSRIs), is used to treat depression, bulimia nervosa, premenstrual dysphoric disorder, panic disorder and post-traumatic stress. According to the amines hypothesis, a functional decrease in the activity of amines, such as serotonin and norepinephrine, would result in depression; a functional increase of the activity of these amines would result in mood elevation. Foxetin's effects are thought to be associated with the inhibition of 5HT receptor, which leads to an increase of serotonin level.
Indication: For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.
Foxetin is used to treat depression. It can also be used to treat anxiety disorders such as panic disorder, social anxiety disorder, obsessive-compulsive disorder (OCD) or an eating disorder known as bulimia nervosa. Foxetin may also be used together with other medicines to treat other depressive conditions as decided by your doctor. Foxetin belongs to a group of antidepressants known as Selective Serotonin Re-uptake Inhibitors (SSRIs).
Indications: bulimia, depression, obsessive-compulsive disorder
selective serotonin reuptake inhibitor indicated for:• Acute and maintenance treatment of Major Depressive Disorder (MDD)in adult and pediatric patients aged 8 to 18 years • Acute and maintenance treatment of Obsessive CompulsiveDisorder (OCD) in adult and pediatric patients aged 7-17 years • Acute and maintenance treatment of Bulimia Nervosa in adult patients• Acute treatment of Panic Disorder, with or without agoraphobia, in adultpatients